nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Lisinopril—dilated cardiomyopathy	0.378	0.532	CbGbCtD
Ticagrelor—ABCB1—Spironolactone—dilated cardiomyopathy	0.333	0.468	CbGbCtD
Ticagrelor—Dyspnoea paroxysmal nocturnal—Lisinopril—dilated cardiomyopathy	0.0643	0.223	CcSEcCtD
Ticagrelor—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00849	0.0295	CcSEcCtD
Ticagrelor—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00768	0.0266	CcSEcCtD
Ticagrelor—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00746	0.0259	CcSEcCtD
Ticagrelor—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.0063	0.0218	CcSEcCtD
Ticagrelor—Gastritis—Spironolactone—dilated cardiomyopathy	0.0061	0.0211	CcSEcCtD
Ticagrelor—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00557	0.0193	CcSEcCtD
Ticagrelor—Gout—Furosemide—dilated cardiomyopathy	0.00553	0.0192	CcSEcCtD
Ticagrelor—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00526	0.0182	CcSEcCtD
Ticagrelor—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00524	0.0182	CcSEcCtD
Ticagrelor—Oliguria—Lisinopril—dilated cardiomyopathy	0.0042	0.0146	CcSEcCtD
Ticagrelor—Gout—Lisinopril—dilated cardiomyopathy	0.00415	0.0144	CcSEcCtD
Ticagrelor—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00351	0.0122	CcSEcCtD
Ticagrelor—Confusional state—Spironolactone—dilated cardiomyopathy	0.00341	0.0118	CcSEcCtD
Ticagrelor—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00305	0.0106	CcSEcCtD
Ticagrelor—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00297	0.0103	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00292	0.0101	CcSEcCtD
Ticagrelor—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00279	0.00968	CcSEcCtD
Ticagrelor—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00268	0.00928	CcSEcCtD
Ticagrelor—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00264	0.00914	CcSEcCtD
Ticagrelor—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00256	0.00888	CcSEcCtD
Ticagrelor—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00254	0.00882	CcSEcCtD
Ticagrelor—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00254	0.00881	CcSEcCtD
Ticagrelor—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0025	0.00865	CcSEcCtD
Ticagrelor—Gastritis—Lisinopril—dilated cardiomyopathy	0.00249	0.00863	CcSEcCtD
Ticagrelor—Eye disorder—Furosemide—dilated cardiomyopathy	0.00242	0.00841	CcSEcCtD
Ticagrelor—Pruritus—Spironolactone—dilated cardiomyopathy	0.0024	0.00831	CcSEcCtD
Ticagrelor—Angiopathy—Furosemide—dilated cardiomyopathy	0.00235	0.00816	CcSEcCtD
Ticagrelor—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00234	0.00812	CcSEcCtD
Ticagrelor—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00232	0.00804	CcSEcCtD
Ticagrelor—Malnutrition—Furosemide—dilated cardiomyopathy	0.00226	0.00783	CcSEcCtD
Ticagrelor—Dizziness—Spironolactone—dilated cardiomyopathy	0.00224	0.00777	CcSEcCtD
Ticagrelor—Vomiting—Spironolactone—dilated cardiomyopathy	0.00215	0.00747	CcSEcCtD
Ticagrelor—Rash—Spironolactone—dilated cardiomyopathy	0.00214	0.00741	CcSEcCtD
Ticagrelor—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00213	0.0074	CcSEcCtD
Ticagrelor—Headache—Spironolactone—dilated cardiomyopathy	0.00212	0.00736	CcSEcCtD
Ticagrelor—Haematuria—Lisinopril—dilated cardiomyopathy	0.00207	0.00717	CcSEcCtD
Ticagrelor—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00204	0.00709	CcSEcCtD
Ticagrelor—Vertigo—Furosemide—dilated cardiomyopathy	0.00203	0.00703	CcSEcCtD
Ticagrelor—Nausea—Spironolactone—dilated cardiomyopathy	0.00201	0.00698	CcSEcCtD
Ticagrelor—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00198	0.00687	CcSEcCtD
Ticagrelor—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00192	0.00666	CcSEcCtD
Ticagrelor—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00192	0.00665	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00191	0.00662	CcSEcCtD
Ticagrelor—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00191	0.00661	CcSEcCtD
Ticagrelor—Confusional state—Furosemide—dilated cardiomyopathy	0.00186	0.00644	CcSEcCtD
Ticagrelor—Shock—Furosemide—dilated cardiomyopathy	0.00181	0.00629	CcSEcCtD
Ticagrelor—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00181	0.00627	CcSEcCtD
Ticagrelor—Skin disorder—Furosemide—dilated cardiomyopathy	0.00179	0.00621	CcSEcCtD
Ticagrelor—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00177	0.00612	CcSEcCtD
Ticagrelor—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00175	0.00608	CcSEcCtD
Ticagrelor—Hypotension—Furosemide—dilated cardiomyopathy	0.00172	0.00597	CcSEcCtD
Ticagrelor—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0017	0.00591	CcSEcCtD
Ticagrelor—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00169	0.00587	CcSEcCtD
Ticagrelor—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00165	0.00574	CcSEcCtD
Ticagrelor—Back pain—Lisinopril—dilated cardiomyopathy	0.00164	0.00568	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00159	0.00552	CcSEcCtD
Ticagrelor—Fatigue—Furosemide—dilated cardiomyopathy	0.00159	0.00551	CcSEcCtD
Ticagrelor—Constipation—Furosemide—dilated cardiomyopathy	0.00158	0.00546	CcSEcCtD
Ticagrelor—Angioedema—Lisinopril—dilated cardiomyopathy	0.00155	0.00537	CcSEcCtD
Ticagrelor—Vertigo—Lisinopril—dilated cardiomyopathy	0.00152	0.00528	CcSEcCtD
Ticagrelor—Syncope—Lisinopril—dilated cardiomyopathy	0.00152	0.00527	CcSEcCtD
Ticagrelor—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00152	0.00527	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00151	0.00523	CcSEcCtD
Ticagrelor—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00149	0.00516	CcSEcCtD
Ticagrelor—Cough—Lisinopril—dilated cardiomyopathy	0.00148	0.00513	CcSEcCtD
Ticagrelor—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00146	0.00505	CcSEcCtD
Ticagrelor—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00146	0.00505	CcSEcCtD
Ticagrelor—Chest pain—Lisinopril—dilated cardiomyopathy	0.00144	0.005	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00143	0.00497	CcSEcCtD
Ticagrelor—Confusional state—Lisinopril—dilated cardiomyopathy	0.00139	0.00483	CcSEcCtD
Ticagrelor—Shock—Lisinopril—dilated cardiomyopathy	0.00136	0.00472	CcSEcCtD
Ticagrelor—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00136	0.00471	CcSEcCtD
Ticagrelor—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00134	0.00466	CcSEcCtD
Ticagrelor—Asthenia—Furosemide—dilated cardiomyopathy	0.00132	0.00458	CcSEcCtD
Ticagrelor—Pruritus—Furosemide—dilated cardiomyopathy	0.0013	0.00452	CcSEcCtD
Ticagrelor—Hypotension—Lisinopril—dilated cardiomyopathy	0.00129	0.00448	CcSEcCtD
Ticagrelor—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00126	0.00437	CcSEcCtD
Ticagrelor—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00124	0.00431	CcSEcCtD
Ticagrelor—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00123	0.00427	CcSEcCtD
Ticagrelor—Dizziness—Furosemide—dilated cardiomyopathy	0.00122	0.00423	CcSEcCtD
Ticagrelor—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00122	0.00422	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00119	0.00414	CcSEcCtD
Ticagrelor—Fatigue—Lisinopril—dilated cardiomyopathy	0.00119	0.00413	CcSEcCtD
Ticagrelor—Constipation—Lisinopril—dilated cardiomyopathy	0.00118	0.0041	CcSEcCtD
Ticagrelor—Vomiting—Furosemide—dilated cardiomyopathy	0.00117	0.00406	CcSEcCtD
Ticagrelor—Rash—Furosemide—dilated cardiomyopathy	0.00116	0.00403	CcSEcCtD
Ticagrelor—Dermatitis—Furosemide—dilated cardiomyopathy	0.00116	0.00403	CcSEcCtD
Ticagrelor—Headache—Furosemide—dilated cardiomyopathy	0.00115	0.004	CcSEcCtD
Ticagrelor—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00114	0.00395	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00113	0.00392	CcSEcCtD
Ticagrelor—Nausea—Furosemide—dilated cardiomyopathy	0.00109	0.0038	CcSEcCtD
Ticagrelor—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00109	0.00379	CcSEcCtD
Ticagrelor—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00109	0.00379	CcSEcCtD
Ticagrelor—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00102	0.00353	CcSEcCtD
Ticagrelor—Asthenia—Lisinopril—dilated cardiomyopathy	0.000992	0.00344	CcSEcCtD
Ticagrelor—Pruritus—Lisinopril—dilated cardiomyopathy	0.000978	0.00339	CcSEcCtD
Ticagrelor—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000946	0.00328	CcSEcCtD
Ticagrelor—Dizziness—Lisinopril—dilated cardiomyopathy	0.000914	0.00317	CcSEcCtD
Ticagrelor—Vomiting—Lisinopril—dilated cardiomyopathy	0.000879	0.00305	CcSEcCtD
Ticagrelor—Rash—Lisinopril—dilated cardiomyopathy	0.000872	0.00302	CcSEcCtD
Ticagrelor—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000871	0.00302	CcSEcCtD
Ticagrelor—Headache—Lisinopril—dilated cardiomyopathy	0.000866	0.003	CcSEcCtD
Ticagrelor—Nausea—Lisinopril—dilated cardiomyopathy	0.000821	0.00285	CcSEcCtD
